Pharma Contractor ApS: Financial statements 2024
CVR: 42247693
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pharma Contractor ApS (CVR 42247693) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 2,850,221 and a net result of DKK 1,438,311 compared with DKK 1,066,441 the year before. That is an increase of 9.8% compared with the year before. Equity in the 2024 report amounted to DKK 1,478,311. The solvency ratio was 73%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,850,221
- Profit/Loss
- DKK 1,438,311
- Equity
- DKK 1,478,311
- Total Assets
- DKK 2,024,315
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 2.9M | 1.4M | 1.5M | 2 |
| 2023 | - | 2.6M | 1.1M | 1.1M | 2 |
| 2022 | - | 1.9M | 585K | 540K | 2 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharma Contractor ApS has published its annual report for 2023. Gross profit came to DKK 2,595,178, and the net result was DKK 1,066,441.
About Pharma Contractor ApS
Pharma Contractor ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2021. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Samina Anwar and Mohammad Masood Anwar. The company is owned by Anwars Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,561,002 and a net result of DKK 1,174,130 compared with DKK 1,438,311 the year before. Equity in the 2025 report amounted to DKK 1,146,081.